AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05540522 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Quadrivalent influenza vaccine
Description: Licensed quadrivalent influenza vaccine (single dose)
Study NCT06217263 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vibration device
Description: Vibracool vibration device from Pain Care Labs will be used.
Study NCT05128253 — intervention group
Intervention type: OTHER
Intervention: High fat meal in a subset of patients with NAFL or NASH
Description: In a subset of NAFL (n=11) and NASH (n=11) patients venous blood samples will also be taken 2 (T0+2h), 4 (T0+4h) and 6 (T0+6h) hours after consumption of a high fat meal.
Study NCT06217263 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vibration device&Cold application pack
Description: Pain Care Labs' Vibracool vibration device and cold gel pack will be used.
Study NCT04992130 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pre-season supplementary neurologic training program
Description: A two-month standardized, pre-season, supplementary multi-modal training program will be prescribed to 200 athletes (intervention cohort) by a team of experienced sport science and medicine professionals targeting the specific intrinsic risk factors of interest identified in the current concussion and ACL prevention literature.
Study NCT06520176 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Day 1\~Day 2: 75mg/m\^2
Study NCT06520176 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cytarabine
Description: Day 1\~Day 2: 200g/m\^2, q12h
Study NCT06520176 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pegfilgrastim
Description: Day 6: 6mg
Study NCT06520176 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cyclophosphamide
Description: Day 1\~Day 2: 1～2g/m\^2
Study NCT06520176 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: G-CSF
Description: Subcutaneous injection at dose 5ug/kg, from day 6 until the end of mobilization.
Study NCT06520176 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: G-CSF
Description: Starting from the 9th day, if the white blood cell count is less than 20,000/μL, administer G-CSF at a dose of 5μg/kg by subcutaneous injection until the collection is completed.
Study NCT06085352 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TetraLens bandage contact lens
Description: Methafilcon-A contact lens eluding tetracaine ophthalmic solution
Study NCT06085352 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Control Acuvue Oasys Bandage contact Lens
Description: Standard of care bandage contact lens
Study NCT05943652 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Tremor recording
Description: Accelerometry following a standardized protocol, using a triaxial accelerometer transducer (Biometrics ACL300, Sensitivity 6 100 mV/G, Biometrics Ltd, UK)
Study NCT06364254 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Cannabidiol Capsules
Description: 300 mg of cannabidiol administered 2 hours before 2 mile run
Study NCT06364254 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Cannabidiol Capsules
Description: 300 mg of cannabidiol administered 2 hours before 2 mile run
Study NCT04845516 — intervention group
Intervention type: OTHER
Intervention: Efficacy of apheresis
Description: Efficacy of apheresis
Study NCT06503549 — intervention group
Intervention type: OTHER
Intervention: Assessments
Description: Only the current assessments will be made
Study NCT05194995 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JAB-21822
Description: JAB-21822 administered orally as a tablet.
Study NCT05194995 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetuximab
Description: Cetuximab administered as an intravenous (IV) infusion.
Study NCT06236646 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Thai dance with twenty-five squares (TDT)
Description: The participants received a Thai dance with twenty-five squares (TDT) program 3 days/week, 12 weeks. This training comprises 10 minutes of warm up, following by 40 minutes of exercise at 40-50% of heart rate reserve at week 1-4, 50-60% of heart rate reserve at week 5-8, and 60-70% of heart rate reserve at week 9-12, 5 minutes of cool down.
Study NCT06236646 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Control (CON)
Description: The CON group did not have any intervention but usual care.
Study NCT05814133 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Thulium Fiber Laser
Description: Thulium Fiber Laser will be used to break renal stones \< 2 cm into fragments small enough to remove or pass spontaneously through the ureter.
Study NCT06337448 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Blue LED
Description: The patient will remain naked, in a closed room, in the lithotomy position on a gynecological table, and he LED will be positioned in the direction of the patient's genitalia, keeping the internal and external vulvar lips open, so the LED can reach the largest possible region for therapeutic action.
Study NCT05232071 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IVA337
Description: 800 mg
Study NCT05232071 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo to match
Study NCT05232071 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Description: 10 mg
Study NCT05541393 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active Intervention Group
Description: The intervention will involve meetings with the church health ministers to discuss COVID-19 vaccines and booster shots.
Study NCT06556186 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transnasal transsphenoidal pituitary lesion resection under neuroendoscopy
Description: Transnasal transsphenoidal pituitary lesion resection under neuroendoscopy
Study NCT06556186 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bromocriptin 2.5mg, 2-3 times a day
Description: Bromocriptin 2.5mg, 2-3 times a day
Study NCT04703855 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HeartMate 3™ left ventricular assist system (HM3 LVAS)
Description: Advanced heart failure patients will be implanted with the HM3 LVAS
Study NCT04915911 — intervention group
Intervention type: OTHER
Intervention: cross-sectional study
Description: cross-sectional study
Study NCT06494800 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: True cut needle biobsy
Description: The biobsy procedure done at the radiology department and the cores are examined by the pathology department, the patient lie prone, supine or in lateral decubitus according to the location of the lesion. A thoracic CT scan was performed first to evaluate the needle pathway and distance from the puncture site to the lesion. The needle pathway was selected to avoid bone, visible vessels, bullae, and fissures. The puncture site was chosen by the CT gantry laser lights and landmarks using a homemade radiopaque grid on the patient's skin. Local anaesthesia was induced with 5 mL of 2% lidocaine. An 18-G coaxial needle was used to puncture the lung, and a repeat CT scan was performed to evaluate the site of the needle. When the needle tip reached the lesion, the specimen was obtained by pressing the trigger of the needle. The specimen was reviewed by the pathologist.The specimen was placed in 10% formaldehyde for pathological examination.
Study NCT05183087 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 3T Connectome MRI
Description: MRI scan of structural connectivity
Study NCT05183087 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 7 Tesla MRI
Description: MRI scan of functional connectivity
Study NCT05183087 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: TSPO PET
Description: PET scan of neuroinflammation
Study NCT05183087 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Tau PET
Description: PET scan of tau deposition
Study NCT05183087 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cognitive and Behavioral Assessments
Description: Assessments of memory, attention, complex reasoning, mood and other cognitive/behavioral domains
Study NCT05183087 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood Biomarkers
Description: Blood-based assessments of proteomic and metabolic biomarkers of brain injury
Study NCT04735731 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Echography
Description: Echography of diaphragma and other respiratory muscles
Study NCT05600881 — intervention group
Intervention type: DRUG
Intervention: Methylphenidate
Description: Participants will take their regular medication or a placebo (vitamin C)
Study NCT04670406 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: acceptance and commitment therapy (ACT) combined with psychoeducation
Description: Participants receive 8 weekly sessions, including 6 ACT sessions and 2 psychoeducation sessions, delivered by trained coaches through Zoom videoconferencing.
Study NCT06459531 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) Therapy
Description: Patients in this group will receive therapy using VR technology. This involves engaging in various sensorimotor training exercises and tasks in an immersive virtual environment. The VR sessions are designed to be interactive and adaptive, providing real-time feedback to the user. The exercises will target the improvement of motor functions, coordination, and strength of the affected upper extremity.~Duration and Frequency: The specific regimen may involve sessions several times a week, with each session lasting between 30 to 60 minutes, over a period of several weeks or months, depending on the study design.
Study NCT06459531 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Conservative Treatment
Description: Patients in this group will receive traditional rehabilitation therapies, which may include:~Physical Therapy (PT): Exercises and activities aimed at improving strength, flexibility, and coordination of the upper limb.~Occupational Therapy (OT): Functional task training to enhance daily living skills and independence, focusing on the use of the upper extremity.~Manual Therapy: Techniques such as massage or joint manipulation to improve mobility and reduce pain.~Home Exercise Programs: Prescribed exercises to be performed at home to reinforce therapy sessions.~Duration and Frequency: Similar to the VR group, this regimen may involve regular sessions several times a week, with each session lasting between 30 to 60 minutes, over a comparable period.
Study NCT05819359 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIA 28-6156 10 mg
Description: BIA 28-6156 10 mg, once daily, oral administration.
Study NCT05819359 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIA 28-6156 60 mg
Description: BIA 28-6156 60 mg, once daily, oral administration.
Study NCT05819359 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo, once daily, oral administration.
Study NCT05946044 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diet and Exercise
Description: Group and individual weight loss and weight maintenance sessions combined with exercise throughout the 48 months.
Study NCT05016271 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Air purifier and fresh air ventilation systems with high-efficiency particulate air (HEPA) filters
Description: This group will receive an intervention of true air purifiers. The air purifiers in classroom (air purifiers and fresh air ventilation systems with HEPA filters) will operate during the school time and the air purifiers in bedrooms (air purifiers with HEPA filters) operate during the home time in the intervention period (4 months anticipated).
Study NCT05016271 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Air purifier and fresh air ventilation systems without high-efficiency particulate air (HEPA) filters
Description: This group will receive an intervention of sham air purifiers. The air purifiers in classroom (air purifiers and fresh air ventilation systems without HEPA filters) will operate during the school time and the air purifiers in bedrooms (air purifiers without HEPA filters) operate during the home time in the intervention period (4 months anticipated).
Study NCT06556979 — intervention group
Intervention type: RADIATION
Intervention: Radiotherapy
Description: Review imaging and medical record of head and neck cancer patient who recieve radiotherpy to find out the incidence of ischemic cerebrovascular event and carotid artery stenosis. The risk factor that influence new carotid artery stenosis was claculated
Study NCT04800419 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Description: ACT is a third generation cognitive behavioral approach which uses acceptance and mindfulness processes, and commitment and behavior change processes to produce psychological flexibility. ACT increase adaptive coping through acceptance, cognitive defusion, mindfulness, and perspective-taking exercises while supporting cancer survivors in aligning behavior with their personal values. The objectives of the therapy are for client to learn to focus on behaviors and actions that are in line with their individual values - the things they care about most. ACT facilitates development and maintenance of health behavioral improvements by targeting internal barriers, such as emotional discomfort and self-defeating thoughts, and by fostering connection and commitment to personal values associated with self-management of positive health behaviors. ACT is useful in cancer patients, because it can help them to deal with the negative emotions caused by cancer instead of avoiding these.
Study NCT04800419 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-based Stress Reduction (MBSR)
Description: The term 'mindfulness' refers to mindful awareness as a way of being - a knowing and experiencing of feelings, thoughts, and perceptions as they arise and pass away each moment. It is a way of relating to all experiences in an open, receptive way, without judging experiences as good or bad (grasping at them or pushing them away). Mindfulness employed two styles of meditations: concentrative meditation involves intentionally focusing attention on a chosen object (e.g. the sensations of breathing) in a sustained way, while receptive meditation involves monitoring the content of experience (e.g. sensations, emotions, thoughts, sounds, etc.) in a non-reactive and non-judgmental way, from moment to moment, with the goal being to recognize the nature of emotional and cognitive patterns. Mindfulness-based stress reduction (MBSR) is an 8-week, standardized group intervention consisting of mindfulness meditation and gentle yoga that is designed to have applications for stress, pain, and illness
Study NCT06066125 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK111
Description: AK111 regimen 1- subcutaneous injection at week 0,1,2, 3,4 and every 4 weeks thereafter until week 48. The primary endpoint will be evaluated at week 12 and followed up to week 56.
Study NCT06066125 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK111
Description: AK111 regimen 2- subcutaneous injection at week 0,1,2, 3,4 and every 4 weeks thereafter until week 48. The primary endpoint will be evaluated at week 12 and followed up to week 56.
Study NCT06066125 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo- subcutaneous injection at week 0,1,2, 3, 4 and week 8. AK111 regimen 2-subcutaneous injection every 4 weeks from week 12 to week 48. The primary endpoint will be evaluated at week 12 and followed up to week 56.
Study NCT05819957 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Therapeutic Education Program (TEP)
Description: the TEP lasts 12 months, being structured into 6 modules.
Study NCT05769114 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Surgical stabilization
Description: Anterior-posterior stabilization (360°) with pedicle screws and an expandable cage
Study NCT05769114 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgical stabilization
Description: Anterior-posterior stabilization (360°) with pedicle screws and an expandable cage
Study NCT05635006 — intervention group
Intervention type: OTHER
Description: No special intervention, randomly classify the subjects
Study NCT05884125 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Checkpoint BEST System
Description: Single use medical device, consisting of electric stimulator and intraoperative lead. Therapy consists of single, 10 minute dose delivered proximal to site of decompression/repair
Study NCT04898777 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biliary drainage
Description: Biliary decompression in cases of distal malignant obstruction by stent placement either using ERCP or EUS.
Study NCT06160986 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Horizons Group Intervention
Description: The Horizons Group intervention in English or Spanish language (per participant preference) contains 8 weekly group sessions delivered via video conference by a bone marrow transplant clinician and behavioral health specialist, over approximately 8 weeks, approximately 1.5 hours per session every week. The intervention pairs state-of-the-science information about survivorship and chronic graft versus host disease with self-management strategies. Intervention sessions will be delivered via video conference (Zoom), which participants may access by computer, laptop, tablet, or smart phone. As part of the intervention, participants will have access to an intervention manual and audio-recorded relaxation exercises to support learning and skills practice.
Study NCT06523621 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: 2 cycles of nivolumab at a dose of 480 mg given over approximately 30-minutes intravenously on Day 1 of each treatment cycle
Study NCT05977322 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 68Ga-FF58
Description: Kit for radiopharmaceutical preparation of 68Ga- FF58 solution for injection
Study NCT05977322 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 177Lu-FF58
Description: Solution for injection/infusion
Study NCT05777889 — intervention group
Intervention type: OTHER
Intervention: Forward Looking InfraRed Camera
Description: Forward Looking InfraRed Camera:~1. We will use a FLIR T420 or T62101 camera with a resolution of 320\*240.~2. Each image will be captured perpendicularly with a 1-inch gap on all four sides.~3. A Myler blanket placed in the background will separate the feet from the background.~4. The camera will be normalized to a temperature range of 15°C to 40°C.~5. The images will be saved in radiometric JPEG format.~6. Once the images have been transferred to a computer, we will remove the background.~7. Next, we'll make a temperature histogram with 0.1°C temperature bin resolution.~8. The before and after histograms (IB, IA) will be compared to see which one indicates more extreme temperature distributions.~9. Those who improve by 30% or more are considered to have had a successful spinal cord stimulation.
Study NCT06407830 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: motor relearning programme
Description: Treatment protocol includes Brief period of warm up and cool down (5 minutes). Individuals of this group will be provided 3 sessions per week; 1 hour per session; 24 sessions of task specific training based on the motor relearning programme. Each task specific training consists of 10 minutes.
Study NCT06407830 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: motor relearning programme
Description: Treatment protocol includes Brief period of warm up and cool down (5 minutes). Individuals of this group will be provided 3 sessions per week; 1 hour per session; 24 sessions of task specific training based on the motor relearning programme. Each task specific training consists of 10 minutes.
Study NCT06407830 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: electrical muscle stimulations with motor relearning programme
Description: Treatment protocol includes Brief period of warm up and cool down (5 minutes). Individuals of this group will be provided 3 sessions per week; 1 hour per session; 24 sessions of task specific training based on the motor relearning programme. Each task specific training consists of 10 minutes.~Individuals of this group will be provided 3 sessions per week; 1 hour per session; 24 sessions for 8 weeks task specific training based on the motor relearning programme and 10 minutes of the EMS of each muscle during the session.
Study NCT06383676 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Functional reaction balance training
Description: The interventions will carried out two days a week and 40 minutes, for eight weeks.
Study NCT06383676 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Functional balance training
Description: The interventions will carried out two days a week and 40 minutes, for eight weeks.
Study NCT06251310 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SW-682
Description: SW-682 tablet administered orally
Study NCT06251310 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combination Therapy
Description: Appropriate combination therapy
Study NCT05424237 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: App intervention
Description: usual care plus app ussage with the aim of promote healthy behaviors (diet, physical activity and weight)
Study NCT05368883 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise- One-Legged
Description: The exercise program consisted of a 5-minute warm-up, followed by 10 minutes of cycling for each leg during the first 2 weeks, increasing to 15 minutes for each leg in the subsequent weeks (with a 5-10 minute rest period between switching legs), and concluded with a 5-minute cool-down period. During the exercise, the inactive leg was kept stationary and in contact with the ground . In the one-legged cycling exercise training, whether patients started with the dominant or non-dominant leg was determined randomly